SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-031950
Filing Date
2015-04-30
Accepted
2015-04-30 07:17:14
Documents
2
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2084
2 EX-24.1 ex-24d1.htm EX-24.1 8272
  Complete submission text file 0001104659-15-031950.txt   11686
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Lydon Nicholas (Reporting) CIK: 0001639935 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37359 | Film No.: 15815130